Skip to: Content
Skip to: Site Navigation
Skip to: Search

December 2, 2008 10:50:25 AM CST

Learn about Newser Points »

« Back to the grid | Next story »

FDA Approved Wrong China Firm

Posted Feb 19, 08 6:26 AM CST in Business,  Science & Health,  World 

(Newser) – The Chinese facility that supplied the active ingredient of the blood-thinner heparin, linked to hundreds of adverse reactions and four US deaths, was never inspected by the FDA because the agency confused it with another plant of the same name, the Washington Post reports. The company was given approval based on an earlier FDA inspection of the other factory. "The wrong firm was put into the database," said the FDA's deputy director.

An FDA team is headed to China now to inspect the right plant to determine what may have caused serious problems with the blood thinner. One of heparin's two manufacturers stopped selling it earlier this month, and the FDA yesterday advised physicians to prescribe alternatives. The FDA's commissioner has recommended inspectors be permanently based in China to address mounting concerns about the safety of Chinese products.

Source Washington Post

0 comments | Print E-mail | Digg Seed this on Newsvine Add this link to Del.icio.us StumbleUpon

Related Newser Stories

  • Feds ID Extra Drug in Baxter's Recalled Heparin

    Mar 19, 08 1:44 PM CDT
    Feds ID Extra Drug in Baxter's Recalled Heparin The Food and Drug Administration has identified the extra ingredient found in samples of Baxter’s blood-thinning drug heparin, the Wall Street Journal reports today. Some batches of the drug—recalled in January after reports of allergic reactions—contained over-sulfated chondroitin sulfate, but it is not certain that was the cause of the hundreds of reactions or 19 deaths linked to Baxter’s product. More »

  • Blood Thinner Woes Hit Germany

    Mar 7, 08 8:32 AM CST
    Blood Thinner Woes Hit Germany Heparin blood thinners may have sickened as many as 100 people in Germany, health officials report. The FDA is currently investigating the drug after it was linked to 19 deaths and hundreds of allergic reactions in the US, possibly due to contaminants from China. The agency is now recommending that all American heparin manufacturers test supplies for contaminants and counterfeit ingredients. More »

  • FDA Finds Contaminant in Blood Thinner

    Mar 5, 08 9:49 PM CST
    FDA Finds Contaminant in Blood Thinner The FDA has found a contaminant in samples of heparin, a blood thinner produced mainly in China linked to 19 deaths and nearly 800 allergic reactions in the US, the New York Times reports. The contaminant may be a counterfeit form of heparin added to reduce its manufacturing cost. The FDA is fine-tuning tests to better detect it. More »

  • Heparin Supply Chain Shaky in China

    Feb 28, 08 2:07 PM CST
    Heparin Supply Chain Shaky in China With at least four US patients dead and hundreds suffering complications from the blood-thinning drug heparin, the New York Times follows the supply chain back to Chinese slaughterhouses that deal with the pig intestines that provide raw material for the drug. Though companies say the chain is secure, the Times finds it vulnerable to contamination and lack of oversight. More »

A syringe of the blood thinner Heparin. FDA inspectors examined the wrong Chinese plant believing they were inspecting one that processed the active ingredient of the widely used drug.   ((c) passamanerie)
Food and Drug Administration Commissioner Andrew von Eschenbach testifies on Capitol Hill. FDA inspectors examined the wrong plantin China believing it processed Heparin.(AP Photo/Susan Walsh)   (Associated Press)
Vials of Heparin made in China
« Prev« Prev | Next »Next » Slideshow
Our editors also recommend:

Made in China

Threads (
1
 of 5)

Tags

China • FDA • blood pressure • Government Accountability Office • pharmaceutical industry • Heparin • John Dingell • Baxter International • inspection • House Energy and Commerce Committee • blood thinner • drug manufacturer


Loading...

Premium Articles from HighBeam

Find more articles like this

Today's Most Popular

Loading...

Other World Stories

What is Newser?

2008 Codie Finalist

Face it: there's too much news. At Newser a team of editors and writers culls the most important stories from hundreds of U.S. and international sources and reduces them to a headline, picture, and two paragraphs. It's the Newser guarantee: we can take any report or column or video and pack what you need to know into 120 words or less. Newser's short-form aggregation, visual format, and unique information tools help you get more of the kind of news you want, in a quicker and more entertaining way. And we do it 24/7—you can come back morning, noon, night (and in between) for something new that matters. Read less, know more.

Learn more »